Cargando…
Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia
Background: Although the prostate-specific antigen (PSA) testing was widely used for early detection of prostate cancer (PCa), it is difficult for PSA to distinguish the PCa from benign prostatic hyperplasia (BPH) patients. Emerging evidence has shown that microRNA (miRNA) was a promising biomarker...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255360/ https://www.ncbi.nlm.nih.gov/pubmed/32489471 http://dx.doi.org/10.7150/jca.45077 |